Monitoring intravesical bacillus Calmette-Guerin treatment of bladder carcinoma with flow cytometry Journal Article


Authors: Staiano-Coico, L.; Huffman, J.; Wolf, R.; Pinsky, C. M.; Herr, H. W.; Whitmore, W. F. Jr; Oettgen, H. F.; Darzynkiewicz, Z.; Melamed, M. R.
Article Title: Monitoring intravesical bacillus Calmette-Guerin treatment of bladder carcinoma with flow cytometry
Abstract: Flow cytometry of bladder irrigation specimens was studied in 22 patients with low stage bladder carcinoma who were treated by transurethral resection of visible tumor followed in 3 to 5 weeks by a course of intravesical bacillus Calmette-Guerin. The most informative examinations were just before the first bacillus Calmette-Guerin treatment, 6 weeks after completing a 6-week course of treatment (3 months) and at 9 months. Of the patients 10 had recurrent tumors after therapy; recurrence was anticipated correctly by flow cytometry at the 12-week followup examination in 6 of the 10 patients and suspected in another. Of 12 patients who remained clinically free of disease for a minimum of 15 months after bacillus Calmette-Guerin therapy flow cytometry identified correctly 7 at 12 weeks, while 1 had a partial response and the remaining 4 reverted to a negative status at 9 months. Of interest, only 4 of the 22 patients were free of disease by flow cytometry at the start of bacillus Calmette-Guerin treatment despite attempted ablation of the tumor by transurethral resection, suggesting that intravesical administration of bacillus Calmette-Guerin destroys existing carcinoma in situ in some cases.
Keywords: clinical article; flow cytometry; monitoring; histology; carcinoma in situ; diagnosis; transurethral resection; bladder carcinoma; therapy; bladder; prevention; bcg vaccination; male genital system; human; priority journal; bladder irrigation
Journal Title: Journal of Urology
Volume: 133
Issue: 5
ISSN: 0022-5347
Publisher: Elsevier Science, Inc.  
Date Published: 1985-05-01
Start Page: 786
End Page: 788
Language: English
DOI: 10.1016/s0022-5347(17)49227-5
PROVIDER: scopus
PUBMED: 3989917
DOI/URL:
Notes: Article -- Export Date: 26 October 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Harry W Herr
    594 Herr
  2. Herbert F Oettgen
    130 Oettgen
  3. Willet F. Whitmore Jr
    139 Whitmore
  4. Myron Melamed
    148 Melamed